13
PATIENTS WITH POLYPHARMACY The importance of closing the loop at care transitions Marjolein Weda, RIVM

PATIENTS WITH POLYPHARMACY - etouches · •Non-suitable dosage form ... Many actors involved with the care for patients with polypharmacy: ... ICT systems not sufficiently facilitating

  • Upload
    lyanh

  • View
    215

  • Download
    0

Embed Size (px)

Citation preview

PATIENTS WITH POLYPHARMACYThe importance of closing the loop at care transitions

Marjolein Weda, RIVM

Polypharmacy

Various definitions available.

In the Netherlands: the chronic use of 5 or more medicines.

Polypharmacie: ca. 45% of the elderly (≥ 65 years)

About 20% of people older than 70 years: 10 or more medicinal products

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 2

Polypharmacy (continued)Most older people live at home, without formal care.

More than 200.000 elderly live at:

• home, with care/nursing;

• care homes;

• nursing homes;

• mental care homes.

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 3

Polypharmacy (continued)

Polypharmacy is a risk factor for avoidable, unplanned hospitalizations.

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 4

Problems experiencedMedication related problems:

• Overuse

• Underus

• Interactions

• Double medication

• Incorrect dose

• Non-suitable dosage form

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 5

Problems experienced (continued)Risk factors:

• Decreased cognition;

• Age;

• Decreased kidney functioning;

• Not living at home (dependent on care);

• Non-adherence;

• Specific medicine classes;

• Knowledge of prescribers/pharmacists;

• Number of prescribers.

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 6

Problems experienced (continued)Many actors involved with the care for patients with polypharmacy:

• General practitioners;

• Medical specialists from various disciplines;

• Nurses;

• Pharmacists;

• Paramedical professionals;

• Mental care professionals;

• Informal caregivers.

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 7

Problems experienced (continued)Several steps in the pharmaceutical care process:

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 8

Prescribing Dispensing Using Monitoring

These steps take place at various settings, by various professionals, at various moments in time.

Detection of problemsMany systems available at different settings:

• Electronic prescription system at general practioner;

• Community pharmacy information system;

• (Electronic) prescription system at hospitals;

• Hospital pharmacy information system;

• (Electronic) prescription system at nursing homes;

• Electronic patient care dossier;

• ……….

Numerous commercial & non-commercial parties involved in setting up and maintaining these systems.

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 9

Detection of problems (continued)Vigilance of drug-drug interactions, drug-disease interactions, contra-indications, correct dosing, underuse, overuse, dubble medication.

Vigilance only work well when all information on patient and medication is available at all time points in the pharmaceutical care process (up-to-date medication history, indications, laboratory values, etcetera).

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 10

Problems experienced in practiceNo adequate communication between professionals;

No adequate communication between patient and professional;

No up-to-date medication history available, during transitions in care;

Not always time to reconcile medicinal products used by patients (urgent care);

Unclear who is directing/responsible;

ICT systems not sufficiently facilitating.

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 11

What is happening in practice?

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 12

THANK YOU FOR YOUR ATTENTION

HTTP://WWW.RIVM.NL/DOCUMENTEN_EN_PUBLICATIES/WETENSCHAPPELIJK/RAPPORTEN/2013/JULI/POLYFARMACIE_BIJ_KWETSBARE_OUDEREN_INVENTARISATIE_VAN_RISICO_S_EN_MOGELIJKE_INTERVENTIESTRATEGIE%C3%ABN

Any questions? Feel free to ask.

[email protected]

11/6/2014 © 2012–2014 Healthcare Information and Management Systems Society (HIMSS) 13